Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (4,247) Arrow Down
Filter Results: (4,247) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (4,247)
    • People  (17)
    • News  (908)
    • Research  (2,744)
    • Events  (10)
    • Multimedia  (35)
  • Faculty Publications  (2,099)

Show Results For

  • All HBS Web  (4,247)
    • People  (17)
    • News  (908)
    • Research  (2,744)
    • Events  (10)
    • Multimedia  (35)
  • Faculty Publications  (2,099)
← Page 30 of 4,247 Results →
  • January 2002 (Revised September 2022)
  • Case

Aqualisa Quartz: Simply a Better Shower

By: Youngme E. Moon and Kerry Herman
Harry Rawlinson is managing director of Aqualisa, a major U.K. manufacturer of showers. He has just launched the most significant shower innovation in recent history: the Quartz shower. The shower provides significant improvements in terms of quality, cost, and ease of... View Details
Keywords: Problems and Challenges; Product Launch; Consumer Behavior; Product Positioning; Technological Innovation; Decision Choices and Conditions; Sales; Strategy; Manufacturing Industry; Manufacturing Industry; United Kingdom
Citation
Educators
Purchase
Related
Moon, Youngme E., and Kerry Herman. "Aqualisa Quartz: Simply a Better Shower." Harvard Business School Case 502-030, January 2002. (Revised September 2022.)
  • 26 Jan 2024
  • Blog Post

HBS Alumna Fighting Cancer with a Novel Cell Therapy

originally planned to pursue a Ph.D., but instead spent four years at Catalent Pharma Solutions, a leading pharma/biotech contract manufacturing development organization. Surrounded by potential career paths in the industry, Zutshi... View Details
  • 08 Feb 2000
  • Research & Ideas

Building Effective R&D Capabilities Abroad

capabilities and product portfolio, the company needed a dedicated laboratory site in East Asia. The new site would support efforts to manufacture and market pharmaceuticals by adapting products to local needs. To that end, the management... View Details
Keywords: by Walter Kuemmerle
  • March 2006
  • Supplement

Geeli (CW)

By: Kenneth A. Froot and Li Jin
A well-performing Chinese manufacturer faces major impediments raising funding to grow. Highlights various imperfections that shape the financing decision. View Details
Keywords: Capital Costs; Diversification; Cost of Capital; Financing and Loans; Financial Strategy; Growth and Development Strategy; Manufacturing Industry; China
Citation
Purchase
Related
Froot, Kenneth A., and Li Jin. "Geeli (CW)." Harvard Business School Spreadsheet Supplement 206-710, March 2006.
  • 29 Oct 2015
  • Blog Post

Why We Recruit: Bloom Energy

opportunities, be sure to visit our job board. What recruiting tactics have you found most successful in engaging with students and/or alumni at HBS? Our most successful recruitment tools have been on-site visits to Bloom Energy’s corporate headquarters and View Details
Keywords: Manufacturing
  • 17 Jan 2013
  • News

The Boeing Debacle: Seven Lessons Every CEO Must Learn

  • March 2011 (Revised October 2011)
  • Case

Mittel Technologies, AG

By: David F. Hawkins
CFO of German heavy equipment manufacturer examines through company examples potential impact of proposed changes to revenue recognition rules. View Details
Keywords: Revenue Recognition; Manufacturing Industry; Germany
Citation
Educators
Purchase
Related
Hawkins, David F. "Mittel Technologies, AG." Harvard Business School Case 111-065, March 2011. (Revised October 2011.)
  • 10 Dec 2012
  • News

Apple Mac To Be Made In USA

  • March 1984 (Revised August 1996)
  • Case

B.F. Goodrich-Rabobank Interest Rate Swap

By: Jay O. Light
A U.S. manufacturing organization and a Eurobank swap fixed and floating rate obligations to reduce their financing costs. View Details
Keywords: Financing and Loans; Cost Management; Production; Interest Rates; Credit Derivatives and Swaps; Auto Industry; Financial Services Industry; United States
Citation
Educators
Purchase
Related
Light, Jay O. "B.F. Goodrich-Rabobank Interest Rate Swap." Harvard Business School Case 284-080, March 1984. (Revised August 1996.)
  • January 2020
  • Case

Wuxi Lead Intelligent Equipment Co., Ltd.

By: John R. Wells and Benjamin Weinstock
In 2019, Wuxi Lead Intelligent Equipment Co., Ltd. (Lead) was the largest supplier of lithium-ion rechargeable battery manufacturing equipment in the world. Based in Wuxi, China, the company generated RMB 3.9 billion ($557 million) in revenues in 2018, up from RMB 175... View Details
Keywords: Lithium-ion Batteries; Electric Vehicles; Government Subsidies; Industry Dynamics; Markets; Change; Strategy; Decision Making; Manufacturing Industry; China
Citation
Educators
Related
Wells, John R., and Benjamin Weinstock. "Wuxi Lead Intelligent Equipment Co., Ltd." Harvard Business School Case 720-419, January 2020.
  • March 2022 (Revised October 2022)
  • Case

Transforming Kimball International, Inc. (A)

By: Lynn S. Paine and Will Hurwitz
Kimball International, Inc. (KII), led by CEO Kristie Juster, and its board of directors, chaired by Kim Ryan, faced critical questions about KII’s future in the spring of 2021. Two years earlier, the board had appointed Juster as the new CEO of KII, a publicly traded,... View Details
Keywords: Board Of Directors; Board Committees; Board Decisions; Board Dynamics; CEO Compensation; CEO Succession; Compensation Committee; Compensation Consultants; Compensation Design; Compensation Mix; Corporate Purpose; COVID-19; ESG; Furniture; Furniture Industry; Manufacturing; Midwest; Pandemic; Purpose; Spin Off; Strategic Change; Strategic Decisions; Strategic Evolution; Target-setting; Executive Compensation; Family Ownership; Governance; Restructuring; Strategy; Transformation; Manufacturing Industry; United States
Citation
Educators
Purchase
Related
Paine, Lynn S., and Will Hurwitz. "Transforming Kimball International, Inc. (A)." Harvard Business School Case 322-083, March 2022. (Revised October 2022.)
  • January 2021 (Revised March 2021)
  • Case

Serum Institute of India (SII): Racing to Save Lives During a Pandemic

By: Rohit Deshpandé, Anjali Raina and Rachna Chawla
The CEO of Serum Institute of India (SII), a $12.8 billion Indian Family business is faced with a risky choice between principles and profit. SII is the largest manufacturer of vaccines in the world and Adar Poonawalla, the CEO and son of the founder has to decide how... View Details
Keywords: Business Ethics; Healthcare; COVID-19; Vaccines; Family Business; Ethics; Health Care and Treatment; Health Pandemics; Leadership; Corporate Accountability; Fairness; Growth and Development Strategy; Health Industry; India; South Asia
Citation
Educators
Purchase
Related
Deshpandé, Rohit, Anjali Raina, and Rachna Chawla. "Serum Institute of India (SII): Racing to Save Lives During a Pandemic." Harvard Business School Case 521-028, January 2021. (Revised March 2021.)
  • March 1994 (Revised November 1994)
  • Case

Komatsu Ltd. (A): Target Costing System

Komatsu, a leading manufacturer of construction equipment, seeks to expand aggressively through the 1990s. Key to its competitiveness is a strict adherence to target costs throughout the product development process. Komatsu conducts several design-for-manufacturability... View Details
Keywords: Cost; Machinery and Machining; Expansion; Product Development; Manufacturing Industry
Citation
Educators
Purchase
Related
Cooper, Robin. "Komatsu Ltd. (A): Target Costing System." Harvard Business School Case 194-037, March 1994. (Revised November 1994.)
  • January 2007 (Revised July 2013)
  • Case

To JV or Not To JV? That Is the Question (for XTech in China)

By: Daniel J. Isenberg and Paul W. Marshall
XTech, a leading manufacturer of metal parts for the telecommunications industry, is being pushed by its large equipment vendor customers to establish a manufacturing operation in China. CEO Reinhold Hesse is debating several options: establishing a joint venture,... View Details
Keywords: Entrepreneurs; Entrepreneurship; Search; Global Ventures; Succession; Acquisitions; Private Equity; Negotiation; Partners and Partnerships; Expansion; Joint Ventures; Management Succession; Decision Choices and Conditions; Corporate Entrepreneurship; Financing and Loans; Global Strategy; Acquisition; Manufacturing Industry; Manufacturing Industry; China; United States
Citation
Educators
Purchase
Related
Isenberg, Daniel J., and Paul W. Marshall. "To JV or Not To JV? That Is the Question (for XTech in China)." Harvard Business School Case 807-118, January 2007. (Revised July 2013.)
  • Jul 2009
  • Article

Restoring American Competitiveness

For decades, U.S. companies have been outsourcing manufacturing in the belief that it held no competitive advantage. That has been a disaster. View Details
  • September 2021 (Revised October 2022)
  • Supplement

Hester Pharmaceuticals (B): Securing Supply

By: Dante Roscini and John Masko
Supplements the (A) case. In late 2020, demand for Hester Pharmaceutical’s (Hester’s) breakthrough oncology drug Akrozumab was outstripping the company’s most optimistic projections. In order to increase manufacturing capacity and meet the demand, Hester was... View Details
Keywords: COVID-19 Pandemic; Cost vs Benefits; Trade; Supply Chain; Global Strategy; Buildings and Facilities; Operations; Health Care and Treatment; Demand and Consumers; Global Range; Globalized Markets and Industries; Pharmaceutical Industry; Italy; China; United States; Germany
Citation
Purchase
Related
Roscini, Dante, and John Masko. "Hester Pharmaceuticals (B): Securing Supply." Harvard Business School Supplement 722-009, September 2021. (Revised October 2022.)
  • Article

Strategic Management of Product Recovery

By: Michael W. Toffel
Manufacturers of an expanding range of durable products are facing regulatory and market pressures to manage the products they manufactured upon their end of life (EOL). In part, this attention is motivated by a growing number of countries—especially across Europe and... View Details
Keywords: Product; Environmental Sustainability; Cost Management; Government Legislation; Logistics; Risk and Uncertainty; Strategy; Europe; Asia; United States
Citation
Find at Harvard
Read Now
Related
Toffel, Michael W. "Strategic Management of Product Recovery." California Management Review 46, no. 2 (Winter 2004): 120–141.
  • 01 Jul 2013
  • News

Family of the Late Boston Businessman William F. Connell Donates $10 Million to Harvard Business School

  • January 2012 (Revised August 2020)
  • Case

The Swatch Group

By: Rohit Deshpandé, Karol Misztal and Daniela Beyersdorfer
In March 2011, Nicolas Hayek, the CEO of the leading Swiss watch manufacturer Swatch Group, reflected on the positioning of Omega, its revived flagship brand. Which marketing strategy would best allow it to confront its main competitor Rolex? And how would potential... View Details
Keywords: Marketing Strategy; Brands and Branding; Segmentation; Product Positioning; Manufacturing Industry; Manufacturing Industry; Manufacturing Industry
Citation
Educators
Purchase
Related
Deshpandé, Rohit, Karol Misztal, and Daniela Beyersdorfer. "The Swatch Group." Harvard Business School Case 512-052, January 2012. (Revised August 2020.)
  • October 2022
  • Case

Cost Plus Drugs

By: Alexander MacKay and James Barnett
In September 2022, Mark Cuban Cost Plus Drugs Company CEO Alex Oshmyansky considered the future of the company. Cost Plus Drugs was a retailer for more than 340 generic oral medications, selling their drugs at significantly lower prices than typical pharmacies.... View Details
Keywords: Business Ventures; Decision Making; Entrepreneurship; Ethics; Health; Markets; Social Enterprise; Society; Strategy; Health Care and Treatment; Business Divisions; Factories, Labs, and Plants; Health Industry; Pharmaceutical Industry; United States; Texas
Citation
Educators
Purchase
Related
MacKay, Alexander, and James Barnett. "Cost Plus Drugs." Harvard Business School Case 723-362, October 2022.
  • ←
  • 30
  • 31
  • …
  • 212
  • 213
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.